Decera Clinical Education Oncology Podcast

Decera Clinical Education

EN253 episodes

educationcourseshealthfitnessmedicinesciencelife

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Notable Guests

EElizabeth Lee, MD1×MMarc Hoffmann, MD1×MMaría-Victoria Mateos, MD, PhD1×DDr. Emanuela Palmerini1×PPier Luigi Zinzani, MD, PhD1×MMafalda Oliveira, MD, PhD1×AAmrita Krishnan1×AAnthony Perissinotti, PharmD, BCOP1×SSam Vafadar, DHSc, PA-C1×

Episodes (253)

Targeting CDH6 in Platinum-Resistant Ovarian Cancer: Emerging ADCs, Biomarkers,...

Decera Clinical Education Oncology Podcast

Sep 4, 202629:16completed

ASCO 2026 Updates in Early Hormone Receptor–Positive Breast Cancer

Decera Clinical Education Oncology Podcast

Sep 4, 20269:10completed

CELMoDs on the Horizon: A New Chapter in Lymphoma Care

Decera Clinical Education Oncology Podcast

Aug 24, 202622:30pending

Experts Discuss Health Disparities and Equitable Care Strategies in Multiple Mye...

Decera Clinical Education Oncology Podcast

Aug 20, 202613:51pending

Experts Discuss CELMoD Agents for Multiple Myeloma

Decera Clinical Education Oncology Podcast

Aug 20, 202626:03pending

Optimizing Oral Targeted Therapies for HR+/HER2- Breast Cancer

Decera Clinical Education Oncology Podcast

Aug 14, 202632:42pending

TGCT Today: Understanding Diagnosis, Treatment, and Long-term Care

Decera Clinical Education Oncology Podcast

Aug 13, 202636:17pending

Optimizing Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple...

Decera Clinical Education Oncology Podcast

Aug 12, 202628:57pending

New and Emerging Targeted Therapies for Patients With DLBCL

Decera Clinical Education Oncology Podcast

Aug 7, 202638:55pending

Changing the Paradigm in HER2-Positive Early Breast Cancer

Decera Clinical Education Oncology Podcast

Aug 7, 202625:04pending

Recent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Ca...

Decera Clinical Education Oncology Podcast

Aug 3, 202617:59pending

To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM

Decera Clinical Education Oncology Podcast

Jul 29, 202648:21pending

Unmet Needs, Recent Advances, and Expert Insights on Integrating TROP-2 ADCs Int...

Decera Clinical Education Oncology Podcast

Jul 28, 202622:12pending

Optimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in...

Decera Clinical Education Oncology Podcast

Jul 23, 202630:58pending

Targeting the Future of Pancreatic Cancer Care: RAS, Biomarkers, and Emerging Th...

Decera Clinical Education Oncology Podcast

Jul 22, 202628:50pending

Beyond BCMA: How GPRC5D-Targeted Therapy Fits into Multiple Myeloma Care Today

Decera Clinical Education Oncology Podcast

Jul 14, 202626:54pending

What Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Re...

Decera Clinical Education Oncology Podcast

Jul 13, 202628:33pending

Incorporating AKT1 and PIK3CA Pathway Testing and Targeted Therapies in the Mana...

Decera Clinical Education Oncology Podcast

Jun 30, 202624:04pending

Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Pra...

Decera Clinical Education Oncology Podcast

Jun 22, 202626:58pending

Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligib...

Decera Clinical Education Oncology Podcast

Jun 9, 202627:23pending

HNSCC: Current and Emerging Therapeutic Strategies

Decera Clinical Education Oncology Podcast

May 29, 202626:24pending

Navigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific An...

Decera Clinical Education Oncology Podcast

May 15, 202620:50pending

Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibo...

Decera Clinical Education Oncology Podcast

May 7, 202631:00pending

Thrombotic Events and ET/PV: What You Should Know

Decera Clinical Education Oncology Podcast

Apr 30, 202622:08failed

Global Experts Discuss Current and Emerging Treatments for ET and PV

Decera Clinical Education Oncology Podcast

Apr 30, 202617:21failed

Global Experts Discuss Diagnostic Considerations in ET and PV

Decera Clinical Education Oncology Podcast

Apr 29, 202614:55failed

Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metasta...

Decera Clinical Education Oncology Podcast

Apr 17, 202622:41failed

Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Earl...

Decera Clinical Education Oncology Podcast

Apr 15, 202641:42failed

Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Exp...

Decera Clinical Education Oncology Podcast

Apr 15, 202631:22failed

Patient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigatio...

Decera Clinical Education Oncology Podcast

Apr 14, 202644:46failed

TROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current U...

Decera Clinical Education Oncology Podcast

Apr 13, 202633:13failed

Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and B...

Decera Clinical Education Oncology Podcast

Apr 13, 202639:12failed

Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC

Decera Clinical Education Oncology Podcast

Mar 26, 202619:16failed

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumo...

Decera Clinical Education Oncology Podcast

Mar 25, 202633:23failed

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumo...

Decera Clinical Education Oncology Podcast

Mar 25, 202622:19failed

Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates...

Decera Clinical Education Oncology Podcast

Mar 23, 202618:57failed

Myth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimiza...

Decera Clinical Education Oncology Podcast

Mar 20, 202625:11failed

From ASH 2025 to the Clinic: Global Perspectives on Evolving BTK Therapies in Re...

Decera Clinical Education Oncology Podcast

Mar 11, 202630:24completed

2025 San Antonio Breast Cancer Symposium Conference Coverage: Highlights Podcast

Decera Clinical Education Oncology Podcast

Mar 9, 202637:14failed

Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Dir...

Decera Clinical Education Oncology Podcast

Mar 9, 202616:44completed

Beyond Chemotherapy in ALL: Emerging Bispecific Antibodies, CAR T-cell Therapies...

Decera Clinical Education Oncology Podcast

Feb 27, 202638:32pending

Experts Discuss Novel RAS-Targeted Therapy for Pancreatic Cancer

Decera Clinical Education Oncology Podcast

Feb 23, 202622:26pending

Advanced Practice Professionals Discuss Biomarker Testing in Patients With Solid...

Decera Clinical Education Oncology Podcast

Feb 20, 202647:50pending

Individualized Hemophilia Care With Hemostatic Rebalancing Therapies

Decera Clinical Education Oncology Podcast

Jan 30, 202629:19pending

Experts Offer Guidance on Shared Decision-making in the Management of Patients W...

Decera Clinical Education Oncology Podcast

Jan 21, 202631:02pending

PulseCast: Highlights in MDS/MPNs From the 2025 ASH Annual Meeting

Decera Clinical Education Oncology Podcast

Dec 30, 202514:59pending

Experts Discuss CELMoD Agents for Treating Multiple Myeloma

Decera Clinical Education Oncology Podcast

Dec 30, 202517:30pending

Expert Highlights From the 2025 World Conference on Lung Cancer

Decera Clinical Education Oncology Podcast

Dec 24, 202524:30pending

PulseCast: Highlights in Multiple Myeloma From the 2025 ASH Annual Meeting

Decera Clinical Education Oncology Podcast

Dec 23, 202515:45pending

PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting

Decera Clinical Education Oncology Podcast

Dec 19, 202514:25pending